SAT0195 Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy: A Single-Center Prospective Cohort Study
SAT0195 Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy: A Single-Center Prospective Cohort Study